Latest Posts:
Search for:
Author

Daniel Garcia

Browsing
In Pharmaceuticals & Biotech

Manufacturing Site Divestitures: Best Practices for Successful Execution

by , , and 11 Mins Read

Pharmaceutical companies are increasingly outsourcing complex manufacturing activities to contract development and manufacturing organizations, or CDMOs. This enables pharmaceutical companies to streamline their operations and redeploy capital toward research and development activities. At the same time, the CDMO industry is booming, with many analysts predicting continued rapid growth. CDMOs need more capacity, and they need it quickly. As a result of these trends, many pharmaceutical companies are engaging in an increasing number of transactions in…

Read More
In Medical Devices

Healthcare & Life Sciences Supply Chains Series: Trade Winds, Tariffs, and Optimizing Operations (2 of 4)

by , , , , , , , and 1 Min Read

Amid fluctuating tariffs and complex trade policies, healthcare and life sciences (HLS) companies face mounting operational and legal challenges within their global supply chains. Organizations are taking steps to retool their supply chains in response to threats against stability, but change introduces myriad knock-on implications. In the second article of the series, we explore four key questions for HLS businesses considering new supply chain strategies:

Read More
In Medical Devices

Healthcare & Life Sciences Supply Chains Series: Strategic Decisions for Business Continuity (1 of 4)

by , , , and 1 Min Read

The healthcare and life sciences sector is facing new trade winds and a looming threat of increased tariffs. This places additional pressure on a typical life sciences supply chain timeline. We recently launched a four-part article series on supply chains, aimed at exploring the legal and operational complexities that healthcare and life sciences companies face as they navigate evolving global supply chain challenges. The first article explores the steps companies can take to ensure business…

Read More